Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS

Дата публикации: 03-08-2026 00:00:00

This cohort study evaluates the association between serum glial fibrillary acidic protein levels and future progression of multiple sclerosis.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Multiple Sclerosis Onset Preceding Epstein-Barr Virus Infection	0	12.53	03-08-2026
2	Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment	0	14.88	14-07-2026
3	Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation	0	8.06	31-07-2026
4	Cessation of Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis—Clinical Trial of the Year	0	9.74	15-07-2026
5	These fat-filled brain cells may be making multiple sclerosis worse	0	7.88	29-06-2026
6	Diverse Research Teams and Underrepresented Groups in Clinical Studies	0	6.4	01-11-2023
7	Gefurulimab and Generalized Myasthenia Gravis	0	10.42	27-07-2026
8	Болезнь с тысячью лиц: диагностика и лечение рассеянного склероза	0	0	20-09-2019
9	White Matter Hyperintensity Burden Is Associated With Altered Functional Network Topology and Enhanced Structural-Functional Coupling in Cerebral Small Vessel Disease	0	7	14-07-2026
10	Mysteries of Your Brain	0	10	06-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.04. Источник: jamanetwork.com.